HIV infection and lipodystrophy

被引:8
|
作者
Kotler, DP [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Med, Div Gastroenterol, New York, NY 10032 USA
关键词
D O I
10.1053/pcad.2003.2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:269 / 284
页数:16
相关论文
共 50 条
  • [21] From lipodystrophy to cardiovascular disease: new insight into the management of HIV infection
    Guaraldi, Giovanni
    Zona, Stefano
    CLINICAL LIPIDOLOGY, 2010, 5 (04) : 583 - 593
  • [22] Commentary on HIV lipodystrophy
    Jones, D
    DERMATOLOGIC SURGERY, 2001, 27 (06) : 610 - 610
  • [23] Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection
    Ioannou, George N.
    Bryson, Christopher L.
    Weiss, Noel S.
    Boyko, Edward J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (05) : 577 - 584
  • [24] Lipodystrophy in pediatric HIV
    Ninad Desai
    Patricia Mullen
    Mudit Mathur
    The Indian Journal of Pediatrics, 2008, 75
  • [25] Lipodystrophy in pediatric HIV
    Desai, Ninad
    Mullen, Patricia
    Mathur, Mudit
    INDIAN JOURNAL OF PEDIATRICS, 2008, 75 (04): : 351 - 354
  • [26] Update on HIV lipodystrophy
    Kravcik, S
    HIV CLINICAL TRIALS, 2004, 5 (03): : 152 - 167
  • [27] Patient drawings and psychological functioning in patients with HIV infection suffering from lipodystrophy
    Fuhrmann, S.
    Thomas, M.
    Petrie, K. J.
    PSYCHOLOGY & HEALTH, 2009, 24 : 178 - 178
  • [28] Surgical treatment of lipodystrophy associated with HIV-infection: Conclusions of a multidisciplinary meeting
    Moreno, S.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2007, 25 (05): : 324 - 328
  • [29] Benign symmetrical lipomatosis (peripheral lipodystrophy) during antiretroviral treatment of HIV infection
    Fischer, T
    Schwörer, H
    Ramadori, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 123 (50) : 1512 - 1516
  • [30] Lipodystrophy syndrome in HIV infection - What is it, what causes it and how can it be managed?
    Behrens, GMN
    Stoll, M
    Schmidt, RE
    DRUG SAFETY, 2000, 23 (01) : 57 - 76